Scientists hunt for clues to make cancer drugs work better for more people
NCT ID NCT07259226
Summary
This international study aims to find better ways to predict which patients with advanced breast, lung, bladder, or stomach cancer will benefit from a newer type of targeted cancer drug called antibody-drug conjugates (ADCs). Researchers will collect blood and tumor samples from 400 patients before and during treatment to look for biological markers that signal whether the treatment is working or if resistance is developing. The goal is to help doctors choose the right drug for each patient and understand why treatments sometimes stop working.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Gustave Roussy Cancer Center
RECRUITINGVillejuif, 94805, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.